Costs And Effectiveness Of Prostate Cancer Screening In Elderly Men
Discusses the possibility of having Medicare cover prostate cancer (PC) screening. Weighs the benefits and risks of screening and considers the possibility that reimbursement by Medicare could help patients make better decisions which would not be based on money alone. Provides information about PC: the basic biology of PC, risk factors for the disease, mortality rates, etc. Presents the technologies available for early detection along with treatment possibilities. Provides studies of: digital rectal exams, prostate-specific antigens, and transrectal ultrasound. Illustrated.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
analysis anesthesia assumptions benign prostatic hyperplasia bone scan Cancer Among Older cancers detected Carcinoma clinicians complications Cost of Early cost-effectiveness death detected cancers Detection and Treatment detection of prostate Digital Rectal Examination DRE and PSA early detection effectiveness estimates expectant management external beam radiotherapy fee schedule followup Health Hybritech impotence incontinence intracapsular cancers Journal of Urology likelihood ratios localized prostate cancer lymph node Massachusetts General Hospital Medical Medicare metastasis metastatic metastatic rate mortality ng/mL Office of Technology one-time screening orchiectomy OTA contract paper outcomes patients percent predictive probability prostate cancer screening prostate capsule Prostate-Specific Antigen radiation therapy radical prostatectomy radiotherapy Richie risk screening benefit screening for prostate screening test sensitivity Specific Antigen Stage strategies studies surgery surgical systematic biopsies Technology Assessment Transrectal ultrasound treated Treatment of Prostate TRNB TRUS tumors TURP U.S. Congress
Page 68 - Steinberg, GD, Carter, BS, Beaty, TH, et al., "Family History and the Risk of Prostate Cancer," 333 " Steineck, G., Adolfsson, J., and Whitmore, WF, "'Local Recurrence' and 'Disease-Free Survival': Doubtful Parameters When Comparing Non-Randomized Studies of Prostate Cancer," Scandinavian Journal of Urology and
Page 70 - Way, LW, (ed.). Current Surgical Diagnosis and Treatment, 9th ed., (East Norwalk, CT: Appleton Lange, 1991). 364 ' Waymont, B., Lynch, TH, Dunn, J., et al., "Treatment Preferences of Urologists in Great Britain and Ireland in the Management of Prostate Cancer,
Page 68 - Stein, A., Dekernion, JB, Smith, RB, et al., "Prostate Specific Antigen Levels After Radical Prostatectomy in Patients with Organ Confined and Locally Extensive Prostate Cancer,
Page 70 - Preventative Services Task Force, "Screening for Prostate Cancer: Commentary on the Recommendations of the Canadian Task Force on the Periodic Health Examination," American Journal of Preventive Medicine
Page 70 - JH, Cushman, CC, Bruskewitz, RC, et al., "A Structured Literature Review of Treatment for Localized Prostate Cancer,